283 results on '"Billaud M"'
Search Results
52. Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms with the Mitogen-Activated Protein Kinase Signaling Cascade
- Author
-
Melillo, R. M., primary, Santoro, M., additional, Ong, S.-H., additional, Billaud, M., additional, Fusco, A., additional, Hadari, Y. R., additional, Schlessinger, J., additional, and Lax, I., additional
- Published
- 2001
- Full Text
- View/download PDF
53. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
- Author
-
Pelet, A, primary, Geneste, O, additional, Edery, P, additional, Pasini, A, additional, Chappuis, S, additional, Atti, T, additional, Munnich, A, additional, Lenoir, G, additional, Lyonnet, S, additional, and Billaud, M, additional
- Published
- 1998
- Full Text
- View/download PDF
54. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts.
- Author
-
Hermeking, H, primary, Wolf, D A, additional, Kohlhuber, F, additional, Dickmanns, A, additional, Billaud, M, additional, Fanning, E, additional, and Eick, D, additional
- Published
- 1994
- Full Text
- View/download PDF
55. Modes supérieurs pour un résonateur électromagnétique à ondes de surface
- Author
-
Billaud, M., primary, Wick, A., additional, Ritoux, G., additional, and Zepp, G., additional
- Published
- 1994
- Full Text
- View/download PDF
56. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.
- Author
-
Hateboer, G, primary, Timmers, H T, additional, Rustgi, A K, additional, Billaud, M, additional, van 't Veer, L J, additional, and Bernards, R, additional
- Published
- 1993
- Full Text
- View/download PDF
57. Nonspecific Increased Serum Levels of Secretory Component in Lung Tumors: Relationship to the Gene Expression of the Transmembrane Receptor Form
- Author
-
Rossel, M., primary, Brambilla, E., additional, Billaud, M., additional, Vuitton, D. A., additional, Blanc-Jouvan, F., additional, Biichle,, S., additional, and Revillard, J. P., additional
- Published
- 1993
- Full Text
- View/download PDF
58. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
- Author
-
Billaud, M., primary, Isselbacher, K. J., additional, and Bernards, R., additional
- Published
- 1993
- Full Text
- View/download PDF
59. Posttranslational modifications in connexins and pannexins.
- Author
-
Johnstone SR, Billaud M, Lohman AW, Taddeo EP, Isakson BE, Johnstone, Scott R, Billaud, Marie, Lohman, Alexander W, Taddeo, Evan P, and Isakson, Brant E
- Abstract
Posttranslational modification is a common cellular process that is used by cells to ensure a particular protein function. This can happen in a variety of ways, e.g., from the addition of phosphates or sugar residues to a particular amino acid, ensuring proper protein life cycle and function. In this review, we assess the evidence for ubiquitination, glycosylation, phosphorylation, S-nitrosylation as well as other modifications in connexins and pannexin proteins. Based on the literature, we find that posttranslational modifications are an important component of connexin and pannexin regulation. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
60. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene
- Author
-
Zimber-Strobl, U, primary, Suentzenich, K O, additional, Laux, G, additional, Eick, D, additional, Cordier, M, additional, Calender, A, additional, Billaud, M, additional, Lenoir, G M, additional, and Bornkamm, G W, additional
- Published
- 1991
- Full Text
- View/download PDF
61. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus
- Author
-
Billaud, M, primary, Rousset, F, additional, Calender, A, additional, Cordier, M, additional, Aubry, JP, additional, Laisse, V, additional, and Lenoir, GM, additional
- Published
- 1990
- Full Text
- View/download PDF
62. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23
- Author
-
Cordier, M, primary, Calender, A, additional, Billaud, M, additional, Zimber, U, additional, Rousselet, G, additional, Pavlish, O, additional, Banchereau, J, additional, Tursz, T, additional, Bornkamm, G, additional, and Lenoir, G M, additional
- Published
- 1990
- Full Text
- View/download PDF
63. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions
- Author
-
Rousset, F., Billaud, M., Blanchard, D., Carl Figdor, Lenoir, G. M., Spits, H., Vries, J. E., and Other departments
- Subjects
Immunology ,Immunology and Allergy ,chemical and pharmacologic phenomena ,hemic and immune systems ,GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries) - Abstract
LFA-1 and LFA-3 expression is absent or low on Burkitt's lymphoma cell lines and low on the EBV-transformed B cell line UD61. Incubation of cells of BL2 and of UD61 with various concentrations of IL-4 resulted in induction of LFA-1 and LFA-3 expression in a dose dependent fashion. This effect was already observed after 16 h of incubation whereas maximal expression was obtained after 72 h. Induction of LFA-1 and LFA-3 expression seemed to be specific for IL-4, because IL-1, IL-2, IL-3, IFN-alpha, IFN-gamma and a low m.w. B cell growth factor were ineffective. LFA-1 and LFA-3 induction by IL-4 was blocked specifically by an anti-IL-4 antiserum. Induction of LFA-1 expression by IL-4 was furthermore confirmed at the specific LFA-1 beta-chain mRNA level. IL-4 was unable to induce LFA-1 expression on EBV-transformed lymphoblastoid cell lines of two LFA-1-deficient patients. BL2 grows as single cells, but induction of LFA-1 and LFA-3 expression by IL-4 was insufficient to induce homotypic cell adhesions and required PMA as a second signal. PMA alone did not induce LFA-1 antigen expression and was unable to induce adhesions between BL2 cells in the absence of IL-4 in 22 h assays. Addition of PMA to BL2 cells that expressed LFA-1 Ag upon incubation with IL-4 resulted in aggregate formation within 30 min. Adhesions between BL2 cells induced by IL-4 in combination with PMA were blocked by anti-LFA-1 beta or anti-LFA-1 alpha-chains mAb. In addition, these mAbs dispersed preformed aggregates of BL2 cells. Our results indicate that IL-4 can induce the adhesion molecules LFA-1 and LFA-3 on B cell lines, but that an additional activation signal provided by PMA was required for the induction of homotypic cell adhesions.
- Published
- 1989
- Full Text
- View/download PDF
64. The RET receptor: function in development and dysfunction in congenital malformation
- Author
-
Manie, S., Santoro, M., Fusco, A., and Billaud, M.
- Published
- 2001
- Full Text
- View/download PDF
65. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.
- Author
-
Segouffin-Cariou, C and Billaud, M
- Abstract
The RET gene codes for a receptor tyrosine kinase that plays a crucial role during the development of both the enteric nervous system and the kidney. Germ line missense mutations at one of six codons specifying extracytoplasmic cysteines are responsible for two related cancer disorders as follows: multiple endocrine neoplasia type2A (MEN2A) and familial medullary thyroid carcinoma (FMTC). MEN2A and FMTC mutations result in a constitutive catalytic activity and as a consequence convert RET into a dominantly acting transforming gene. Although it has been shown that RET-MEN2 mutants activate several transduction pathways, their respective contribution to the neoplastic phenotype remains poorly understood. Over the past few years, it has become increasingly clear that the transforming ability of several viral and cellular oncoproteins depends on their capacity to activate phosphatidylinositol 3-kinase (PI3K). We now report that RET carrying a representative MEN2A mutation at Cys-634 (termed RET-MEN2A) activates PI3K and its downstream effector, the serine/threonine kinase AKT/protein kinase B. Previous studies have demonstrated that mutation of Tyr-1062, which is the intracellular docking site for Shc and Enigma on RET, abolishes the RET-MEN2A transforming activity. We provide evidence that mutation of Tyr-1062 abrogates the binding of the p85 regulatory subunit of PI3K to RET-MEN2A and the subsequent stimulation of the PI3K/AKT pathway. Furthermore, infection of rat fibroblasts with a retrovirus expressing a dominant-interfering form of PI3K suppresses RET-MEN2A-dependent transformation, whereas overexpression of AKT enhances the RET-MEN2A oncogenic potential. In summary, these data are consistent with the notion that RET-mediated cell-transforming effect is critically dependent on the activation of the PI3K/AKT pathway.
- Published
- 2000
66. GDNF triggers a novel Ret-independent Src kinase family-coupled signaling via a GPI-linked GDNF receptor @a1
- Author
-
Poteryaev, D., Titievsky, A., Sun, Y.F., Thomas-Crusells, J., Lindahl, M., Billaud, M., Arumae, U., and Saarma, M.
- Published
- 1999
- Full Text
- View/download PDF
67. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
- Author
-
Calender, A, Billaud, M, Aubry, J P, Banchereau, J, Vuillaume, M, and Lenoir, G M
- Abstract
A set of B-cell activation markers, including the EBV/C3d receptor [complement receptor type 2 (CR2) (CD21)], the 45-kDa lymphoblastoid cell-associated (Blast-2) antigen (CD23), and the B-cell restricted activation (Bac-1) antigen (which was recently identified as a potential B-cell growth factor receptor) can be turned on by infecting lymphoma cells that are genome negative for Epstein-Barr virus (EBV) with the B95-8 immortalizing strain of the virus. The nonimmortalizing EBV variant, strain P3HR-1, which possesses a deletion within the BamHI WYH region of the genome containing the coding sequence for the EBV-determined nuclear antigen 2, does not induce expression of these markers. Other lymphoblastoid cell-associated antigen markers can be activated by infection with either immortalizing or nonimmortalizing viruses. These results suggest that the immortalizing potential of EBV is correlated with its ability to induce expression of B-cell activation markers, which are suspected to play a major role in the physiological pathway leading to lymphoid cell proliferation. The viral genomic region deleted in the nonimmortalizing strain of EBV seems to be required for activation of some of these markers. Human lymphoma cell lines, such as those used in this study, can thus help identify the specific EBV genes involved in lymphoid B-cell proliferation and the mechanism of action of these genes.
- Published
- 1987
- Full Text
- View/download PDF
68. Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2
- Author
-
Billaud, M, Busson, P, Huang, D, Mueller-Lantzch, N, Rousselet, G, Pavlish, O, Wakasugi, H, Seigneurin, J M, Tursz, T, and Lenoir, G M
- Abstract
Anaplastic nasopharyngeal carcinoma (NPC) cells invariably harbor the Epstein-Barr virus (EBV) genome, an association that is unique among human virus-associated cancers. Although EBV is able to replicate in epithelial cells, results with expression of the EBV receptor (complement receptor type 2 [CR2]; also called CD21) in normal and malignant epithelial cells are conflicting. We grew five different EBV-associated NPC tumors in nude mice, and by using a sensitive transcriptional assay, we detected a very weak transcription signal of the EBV receptor CR2 gene in these cells. This suggests that low levels of EBV receptor may be expressed by malignant epithelial nasopharyngeal cells. The gene coding for Blast2/CD23, a B-cell activation molecule induced by EBV, was transcribed in three of the transplanted NPC tumors. The soluble form of the Blast2/CD23 protein was also detected in medium taken from short-term cultures of the same NPC cell lines. In contrast to the lymphoid system, in which Blast2/CD23 expression is associated with EBV nuclear antigen (EBNA2) expression, no EBNA2 protein could be detected in these NPC epithelial cells. Our study represents the first demonstration of Blast2/CD23 expression in epithelial cells. As the soluble form of the Blast2/CD23 protein possesses growth factor activity associated with EBV-induced B-cell immortalization, these results suggest a possible role for this molecule in the pathogenesis of NPC.
- Published
- 1989
- Full Text
- View/download PDF
69. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex.
- Author
-
Rouault, J P, Prévôt, D, Berthet, C, Birot, A M, Billaud, M, Magaud, J P, and Corbo, L
- Abstract
Both BTG1 and BTG2 are involved in cell-growth control. BTG2 expression is regulated by p53, and its inactivation in embryonic stem cells leads to the disruption of DNA damage-induced G2/M cell-cycle arrest. In order to investigate the mechanism underlying Btg-mediated functions, we looked for possible functional partners of Btg1 and Btg2. Using yeast two-hybrid screening, protein-binding assays, and transient transfection assays in HeLa cells, we demonstrated the physical in vitro and in vivo interaction of both Btg1 and Btg2 with the mouse protein mCaf1 (i.e. mouse CCR4-associated factor 1). mCaf1 was identified through its interaction with the CCR4 protein, a component of a general transcription multisubunit complex, which, in yeast, regulates the expression of different genes involved in cell-cycle regulation and progression. These data suggest that Btg proteins, through their association with mCaf1, may participate, either directly or indirectly, in the transcriptional regulation of the genes involved in the control of the cell cycle. Finally, we found that box B, one of two conserved domains which define the Btg family, plays a functional role, namely that it is essential to the Btg-mCaf1 interaction.
- Published
- 1998
70. The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype
- Author
-
Carlomagno, F., Salvatore, G., Cirafici, A. M., Vita, G., Melillo, R. M., Francisas, V., Billaud, M., Alfredo Fusco, Santoro, M., Carlomagno, Francesca, G., Salvatore, A. M., Cirafici, DE VITA, Gabriella, Melillo, ROSA MARINA, V. d., Francisci, M., Billaud, Fusco, Alfredo, and Santoro, Massimo
- Subjects
Proto-Oncogene Proteins c-ret ,Receptor Protein-Tyrosine Kinases ,Multiple Endocrine Neoplasia Type 2a ,3T3 Cells ,Neoplastic, Mice, Molecular Weight, Multiple Endocrine Neoplasia Type 2a ,PC12 Cells ,Rats ,Gene Expression Regulation, Neoplastic ,Molecular Weight ,Mice ,Phenotype ,genetics, PC12 Cells, Phenotype, Point Mutation, Proto-Oncogene Proteins c-ret, Proto-Oncogene Protein ,genetics, Proto-Oncogenes, Rats, Receptor Protein-Tyrosine Kinase ,Proto-Oncogene Proteins ,Proto-Oncogenes ,Animals ,Drosophila Proteins ,Point Mutation ,genetics ,3T3 Cells, Animals, Drosophila Proteins, Gene Expression Regulation - Abstract
Distinct point mutations of RET, a tyrosine-kinase receptor encoding gene, are responsible for the inheritance of multiple endocrine neoplasia type 2 syndromes (MEN2A and MEN2B) and familial medullary thyroid carcinoma (FMTC). In particular, MEN2A is a more complex and aggressive disease than FMTC, being characterized by pheochromocytomas and parathyroid alterations, in addition to medullary thyroid carcinomas. The mutations associated with MEN2A and FMTC affect one of five cysteine residues mapping in the extracellular domain of the Ret protein. However, recent studies have indicated that MEN2A and FMTC disease phenotypes correlate with the position of mutations in RET. Mutations of Cys-634 are more frequent in families with MEN2A, whereas Cys-620 mutations are very rarely found in MEN2A patients and, in contrast, are frequently found in FMTC patients. We have reported previously that mutations of Cys-634 constitutively activate the RET transforming potential by causing a disulfide bridge-mediated homodimerization. Here, we report that the mutation Cys-620 --> Tyr is able to cause a constitutive dimerization of Ret, with consequent activation of its kinase and transforming activities, to a lower extent than mutation of Cys-634. We suggest that the difference in ability to activate RET shown by mutations associated with FMTC and MEN2A represents the molecular basis of the phenotypic diversity between the two syndromes.
71. Neural crest and multiple endocrinopathies,Crête neurale et polyendocrinopathies
- Author
-
Pasini, A., Michiels, F. M., Chappuis-Flament, S., Geneste, O., Rossel, M., Fournier, L., Jean Feunteun, Lenoir, G., Schuffenecker, I., and Billaud, M.
72. Ondes electromagnétiques de surface en géométrie cylindrique. Les modes de révolution d'ordre supérieur
- Author
-
Zepp, G., primary, Wick, A., additional, Ritoux, G., additional, Fabre, G., additional, and Billaud, M., additional
- Published
- 1985
- Full Text
- View/download PDF
73. Real measures, virtual instruments
- Author
-
Billaud, M., primary, Zimmer, T., additional, Geoffroy, D., additional, Danto, Y., additional, Effinger, H., additional, Seifert, W., additional, Martinez, J., additional, and Gomez, F., additional
- Full Text
- View/download PDF
74. Integration of Remote Lab Exercises into Standard Course Packages.
- Author
-
Zimmer, T., Billaud, M., and Geoffroy, D.
- Subjects
CURRICULUM ,EDUCATIONAL objectives ,LABORATORIES ,INSTRUCTIONAL materials centers ,HOMEWORK - Abstract
We propose to integrate remote lab exercises into standard course packages. A standard course package consists in classroom sessions, exercise sessions and lab sessions, the whole completed by homework for following up and preparing the different sessions. Homework is crucial in the learning process and we have developed a dedicated platform integrating four levels of activities accompanying each lesson. The first level recalls the learning objectives and learning contents of each lesson. The corresponding exercises are proposed in a second level. An auto-evaluation can be done in a third level. Finally, lab exercises are proposed for each topic in the forth level. The whole is organised in a hierarchical tree structure for easy navigation and a good overview. [ABSTRACT FROM AUTHOR]
- Published
- 2007
75. Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension
- Author
-
Dahan Diana, Billaud Marie, Marthan Roger, Savineau Jean-Pierre, and Guibert Christelle
- Subjects
pulmonary hypertension ,gap junctions ,connexin ,vasoreactivity ,chronic hypoxia ,monocrotaline ,connexin-mimetic peptides ,Diseases of the respiratory system ,RC705-779 - Abstract
Background Pulmonary hypertension (PH) is characterized by arterial vascular remodelling and alteration in vascular reactivity. Since gap junctions are formed with proteins named connexins (Cx) and contribute to vasoreactivity, we investigated both expression and role of Cx in the pulmonary arterial vasoreactivity in two rat models of PH. Methods Intrapulmonary arteries (IPA) were isolated from normoxic rats (N), rats exposed to chronic hypoxia (CH) or treated with monocrotaline (MCT). RT-PCR, Western Blot and immunofluorescent labelling were used to study the Cx expression. The role of Cx in arterial reactivity was assessed by using isometric contraction and specific gap junction blockers. Contractile responses were induced by agonists already known to be involved in PH, namely serotonin, endothelin-1 and phenylephrine. Results Cx 37, 40 and 43 were expressed in all rat models and Cx43 was increased in CH rats. In IPA from N rats only, the contraction to serotonin was decreased after treatment with 37-43Gap27, a specific Cx-mimetic peptide blocker of Cx 37 and 43. The contraction to endothelin-1 was unchanged after incubation with 40Gap27 (a specific blocker of Cx 40) or 37-43Gap27 in N, CH and MCT rats. In contrast, the contraction to phenylephrine was decreased by 40Gap27 or 37-43Gap27 in CH and MCT rats. Moreover, the contractile sensitivity to high potassium solutions was increased in CH rats and this hypersensitivity was reversed following 37-43Gap27 incubation. Conclusion Altogether, Cx 37, 40 and 43 are differently expressed and involved in the vasoreactivity to various stimuli in IPA from different rat models. These data may help to understand alterations of pulmonary arterial reactivity observed in PH and to improve the development of innovative therapies according to PH aetiology.
- Published
- 2011
- Full Text
- View/download PDF
76. Signalling pathways involved in 5-HT-induced contraction dependent on connexin 43 and superoxide anion production in rat intrapulmonary arteries.
- Author
-
Khoyrattee, N., Billaud, M., Bourdieu, A., Cardouat, G., Marthan, R., Savineau, J., and Guibert, C.
- Subjects
- *
SEROTONIN , *SMOOTH muscle , *CONNEXINS - Abstract
We previously showed that serotonin (5-HT) produces superoxide anion (O2∸) in the intrapulmonary artery (IPA) smooth muscle. Then, O2∸ passes through the myoendothelial junction (connexin (Cx) 43) to decrease the bioavailability of endothelial NO and strengthen IPA vasoreactivity (Billaud et al., 2009). Here, we further addressed the signalling pathways involved in such process. Male Wistar rats were humanely killed according to national guidelines. IPA were used for immunofluorescence labellings and recording of O2∸ levels by electron paramagnetic resonance (EPR). Mitochondrial Ca2+ (Ca2+m) was assessed in smooth muscle cells with Rhod-2. Isometric contraction was recorded on IPA rings with an organ bath system. Results were expressed as mean ± S.E.M. Significance was considered when P<0.05 and tested with Mann-Whitney (unpaired samples) and Student t-Test (paired samples). n represents the number of rats for EPR and immunofluorescence, the number of arterial rings for the contractile studies and the number of cells for Ca2+m recordings. 5-HT (100 μM) significantly increased O2∸ levels in rat IPA (8672.8 ± 752.9 arbitrary units per mg⋅ml-1 of proteins in response to 5-HT vs 5205 ± 589.7 in basal conditions, n=12-13). Endothelin-1 (ET-1) (0.1 μM) and phenylephrine (Phe) (10 μM) had no effect. Ketanserin (1 μM), a blocker of 5-HT2A receptors significantly decreased 5-HT-induced O2∸ production whereas blocking the 5-HT1B receptors and the 5-HT transporter (5-HTT) by GR 127935 (1 μM) or citalopram (1 μM) respectively had no effect (n=11-12). EPR recordings showed that removal of extracellular Ca2+ (Ca2+e) decreased 5-HT-induced O2∸ increase (6310 ± 585.8, p=0.016) whereas depleting intracellular Ca2+ stores with thapsigargin (1 μM) had no effect (n=12-13). Blockers of O2∸ sources namely apocynin (30 μM) and rotenone (5 μM) for NADPH oxidase (Nox) and the complex I of the mitochondrial respiratory chain (MRCI) respectively, reduced 5-HT-induced O2∸ increase (n = 10-19). 5-HT enhanced the Ca2+m level with or without Ca2+e (n=30-40). Inhibition of PKCε significantly reduced O2∸ production to its basal level (n=8-9). Unlike 5-HT1B and ETB receptors, both 5-HT2A and α1D receptors (Phe receptors) colocalised with Cx 43.5-HT2A receptors and Cx 43 also colocalised with caveolin-1. Unlike the contraction to ET-1, the contraction to 5-HT and Phe was significantly modified after caveolae removal with methyl-β-cyclodextrin (7 mM) (n=12-26). Altogether, 5-HT acts on 5-HT2A receptors and induces a calcium influx responsible for Ca2+m increase and O2∸ production (via MRCI). This process activates PKCε which in turn may activate O2∸ production by Nox. Interestingly, O2∸ production in rat IPA seems to be 5-HT specific and would happen in caveolae localised near to Cx43. [ABSTRACT FROM AUTHOR]
- Published
- 2013
77. Role of Pannexin 1 in the regulation of blood pressure.
- Author
-
Billaud, M., Parpaite, T., Chiu, Y., Lohman, A. W., Mutchler, S. M., Sandilos, J. K., Bayliss, D. A., and Isakson, B. E.
- Subjects
- *
PANNEXINS , *MUSCLE cells , *SMOOTH muscle - Abstract
We demonstrated that pannexin1 (Panx1) channels are expressed in the smooth muscle cells of small arteries where they participate in α1D adrenergic receptor (α1DAR)-mediated vasoconstriction1. In this paper, we also showed that ATP is released from vascular smooth muscle cells via Panx1 channels upon phenylephrine (PE) stimulation. Since the α1DAR-mediated constriction as well as ATP signaling are key in the regulation of peripheral resistance and blood pressure, we hypothesized that Panx1 could participate in blood pressure regulation. Therefore, we created an inducible conditional KO mouse model where Panx1 is deleted specifically in smooth muscle cells by breeding smooth muscle myosin heavy chain (SMMHC) - CreER T2+ mice with Panx1 fl/fl mice. After 10 days of tamoxifen injections, the expression of Panx1 in arterial smooth muscle cells was abolished and the vasoconstriction of small arteries in response to PE was significantly reduced. Using radiotelemetry, we measured a reduction in the mean arterial pressure in these mice after tamoxifen injections. Because Panx1 is activated by the α1DAR signaling cascade and because the channel and the receptor are closely located at the plasma membrane of arterial smooth muscle cells, we hypothesized that disruption of the Panx1/α1DAR signaling pathway would alter vasoconstriction. In order to specifically inhibit Panx1 activation by the α1DAR, we designed a peptide mimicking the intracellular loop (IL) region of Panx1, which is enriched in proline, making this region more susceptible to interact with protein partners for intracellular signaling. When treated with the IL peptide, pressurized small arteries exhibited decreased vasoconstriction to PE. In parallel, we performed electrophysiology on HEK cells co-transfected with Panx1 and α1DAR plasmids and confirmed PE-induced Panx1 activation in vitro by measuring an increase of Panx1 current and ATP release upon PE stimulation. The PE-induced Panx1 activation was also altered by Panx1 IL peptide. To further investigate the key amino acids of Panx1 intracellular loop in PE-induced Panx1 activation, we created specific mutants of Panx1 in the region mimicked by the IL peptide and cotransfected these mutants in HEK cells along with the α1DAR plasmid. Both ATP release and Panx1 currents were decreased when the amino acids YLK in position 198 to 200 were mutated to alanine, showing their essential role in PE-induced Panx1 activation. In summary, our results show that Panx1 plays an essential role in the α1DAR-mediated constriction by releasing ATP and thus in the regulation of blood pressure. Furthermore, we have identified a key region in Panx1 intracellular loop that is essential in the PE-induced activation of Panx1. This work provides the basis for a novel understanding of blood pressure control by the sympathetic nervous system. [ABSTRACT FROM AUTHOR]
- Published
- 2013
78. Signalling pathways involved in the superoxide anion production in response to serotonin in rat intrapulmonary arteries.
- Author
-
Billaud, M., Khoyrattee, N., Marthan, R., Savineau, J., and Guibert, C.
- Published
- 2011
79. Real measures, virtual instruments.
- Author
-
Billaud, M., Zimmer, T., Geoffroy, D., Danto, Y., Effinger, H., Seifert, W., Martinez, J., and Gomez, F.
- Published
- 2002
- Full Text
- View/download PDF
80. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret
- Author
-
Marc Billaud, Rosa Marina Melillo, Francesca Carlomagno, Pietro Formisano, Alfredo Fusco, Giancarlo Vecchio, Massimo Santoro, Gabriella De Vita, Melillo, ROSA MARINA, Carlomagno, Francesca, DE VITA, Gabriella, Formisano, Pietro, Vecchio, Giancarlo, Fusco, Alfredo, Billaud, M., and Santoro, Massimo
- Subjects
endocrine system ,congenital, hereditary, and neonatal diseases and abnormalities ,Cancer Research ,endocrine system diseases ,Insulin Receptor Substrate Proteins ,Amino Acid Motifs ,Protein Serine-Threonine Kinases ,Biology ,Binding, Competitive ,Mice ,Phosphatidylinositol 3-Kinases ,Proto-Oncogene Proteins ,Genetics ,PI3-K ,Animals ,Drosophila Proteins ,Neoplastic transformation ,Phosphorylation ,IRS-1 ,neoplasms ,Molecular Biology ,Protein kinase B ,Binding Sites ,Proto-Oncogene Proteins c-ret ,tyrosine kinase ,RNA-Binding Proteins ,Receptor Protein-Tyrosine Kinases ,3T3 Cells ,Phosphoproteins ,Insulin receptor ,Amino Acid Substitution ,Ribonucleoproteins ,Mutation ,Cancer research ,biology.protein ,Signal transduction ,RET ,Proto-Oncogene Proteins c-akt ,Polypyrimidine Tract-Binding Protein ,Congenital megacolon - Abstract
Tyrosine 1062 of Ret, which represents an intracytoplasmic docking site for multiple signaling molecules, is essential for Ret-mediated activation of phosphatidylinositol 3-Kinase (PI3-K). PI3-K, in turn, has been implicated in inducing cell survival and neoplastic transformation mediated by Ret. We have examined the mechanisms by which Ret stimulates PI3-K. Here we show that the Insulin Receptor Substrate-1 (IRS-1) is tyrosine phosphorylated and associated with the p85 regulatory subunit of PI3-K in response to Ret activation. IRS-1 coimmunoprecipitates with Ret and co-expression of IRS-1 results in the potentiation of Ret-mediated activation of Akt(PKB), a bona fide effector of PI3-K. The association with the PTB domain of IRS-1 depends on the phosphorylation of tyrosine 1062 of Ret. The deletion of asparagine 1059 (delN1059) and the substitution of leucine 1061 (L1061P), two Ret mutations identified in families affected by congenital megacolon (Hirschsprung's disease), impair the binding of IRS-1 to Ret as well as Ret-mediated Akt(PKB) stimulation. Finally, we show that Shc, which was previously identified as another ligand of Y1062 of Ret, competes with IRS-1 for the binding to Ret pY1062. All together, these findings suggest that IRS-1 is a component of the signaling pathway which leads to Ret-mediated PI3-K activation, a pathway which can be targeted by Hirschsprung-associated Ret mutations. The alternative binding of Shc and IRS-1 to Ret pY1062 can be a system to modulate the activation of different intracellular signaling pathways and to elicit different biological responses following Ret activation.
- Published
- 2001
- Full Text
- View/download PDF
81. Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer
- Author
-
Joseph M. Gozgit, Marc Billaud, Liborio Torregrossa, Fulvio Basolo, Magesh Muthu, Preziosa Buonocore, Valentina De Falco, Massimo Santoro, Francesca Carlomagno, De Falco, V, Buonocore, Preziosa, Muthu, M, Torregrossa, L, Basolo, F, Billaud, M, Gozgit, Jm, Carlomagno, Francesca, and Santoro, Massimo
- Subjects
endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,Nude ,Clinical Biochemistry ,Drug Resistance ,Biochemistry ,Tyrosine-kinase inhibitor ,chemistry.chemical_compound ,Mice ,Random Allocation ,Endocrinology ,thyroid cancer ,Phosphorylation ,Tumor ,Kinase ,Ponatinib ,Imidazoles ,tyrosine kinase ,Recombinant Proteins ,Tumor Burden ,Diabetes and Metabolism ,Pyridazines ,Neuroendocrine ,Proto-Oncogene Proteins c-ret ,Female ,Tyrosine kinase ,medicine.medical_specialty ,congenital, hereditary, and neonatal diseases and abnormalities ,endocrine system ,medicine.drug_class ,Mice, Nude ,Context (language use) ,Animals ,Antineoplastic Agents ,Carcinoma ,Carcinoma, Neuroendocrine ,Cell Line ,Cell Line, Tumor ,Cell Proliferation ,Drug Resistance, Neoplasm ,Humans ,Mutant Proteins ,Protein Kinase Inhibitors ,Protein Processing, Post-Translational ,Thyroid Neoplasms ,Xenograft Model Antitumor Assays ,Biochemistry (medical) ,Biology ,Internal medicine ,medicine ,Kinase activity ,neoplasms ,Protein Processing ,Cell growth ,Post-Translational ,chemistry ,Cancer research ,Neoplasm ,RET - Abstract
CONTEXT: The RET tyrosine kinase encoding gene acts as a dominantly transforming oncogene in thyroid carcinoma and other malignancies. Ponatinib (AP24534) is an oral ATP-competitive tyrosine kinase inhibitor that is in advanced clinical experimentation in leukemia. OBJECTIVE: We tested whether ponatinib inhibited RET kinase and oncogenic activity. METHODS: Ponatinib activity was studied by an in vitro RET immunocomplex kinase assay and immunoblotting. The effects of ponatinib on proliferation of human TT, MZ-CRC-1, and TPC-1 thyroid carcinoma cells, which harbor endogenous oncogenic RET alleles, and of NIH3T3 fibroblasts transfected with oncogenic RET mutants were determined. Ponatinib activity on TT cell xenografted tumors in athymic mice was measured. RESULTS: Ponatinib inhibited immunopurified RET kinase at the IC50 of 25.8 nM (95% confidence interval [CI] = 23.15-28.77 nM). It also inhibited (IC50 = 33.9 nM; 95% CI = 26.41-43.58 nM) kinase activity of RET/V804M, a RET mutant displaying resistance to other tyrosine kinase inhibitor. Ponatinib blunted phosphorylation of point-mutant and rearranged RET-derived oncoproteins and inhibited proliferation of RET-transformed fibroblasts and RET mutant thyroid carcinoma cells. Finally, after 3 weeks of treatment with ponatinib (30 mg/kg/d), the volume of TT cell (medullary thyroid carcinoma) xenografts was reduced from 133 mm(3) to an unmeasurable size (difference = 133 mm(3), 95% CI = -83 to 349 mm(3)) (P < .001). Ponatinib-treated TT cell tumors displayed a reduction in the mitotic index, RET phosphorylation, and signaling. CONCLUSIONS: Ponatinib is a potent inhibitor of RET kinase and has promising preclinical activity in models of RET-driven medullary thyroid carcinoma.
- Published
- 2013
82. Is Co-option a prevailing mechanism during cancer progression?
- Author
-
Massimo Santoro, Marc Billaud, Billaud, M, and Santoro, Massimo
- Subjects
Cancer Research ,Epithelial-Mesenchymal Transition ,Adaptation, Biological ,Tumor cells ,Biology ,Models, Biological ,Malignant transformation ,Metastasis ,Substrate Specificity ,Evolution, Molecular ,Gene Duplication ,Neoplasms ,oncogenesi ,Selective advantage ,medicine ,Malignant cells ,Animals ,Humans ,Epigenetics ,Neoplasm Metastasis ,Selection, Genetic ,Genetics ,Hemostasis ,Neovascularization, Pathologic ,Cancer type ,medicine.disease ,Neoplasm Proteins ,Gene Expression Regulation, Neoplastic ,Oncology ,Mutation ,Disease Progression ,metastasi ,signaling ,Neuroscience ,Glycolysis - Abstract
Cancer progression results from the accumulation of genetic and epigenetic alterations that provide tumor cells with a selective advantage. The consecutive cycles of mutations, selections, and clonal expansions generate, over time, descendant cells with increasing malignant properties. Although this conception of tumor development rests on solid experimental foundations, it has also raised several persisting questions. Does the succession of mutations dictate the progression of each cancer type or does the disturbance of an invariant set of regulatory circuits govern tumor evolution regardless of the linear order of genetic events? Is the ability of malignant cells to disseminate and spawn metastasis a property acquired at late stages of tumor development or is the proclivity to metastasize implanted early during cancer formation? Considering these issues, we elaborate here on the concept of co-option that refers to the emergence of novel functions from ancestral characters during episodes of organismal evolution. As discussed in this Perspective, co-option seems to be a key mechanism propelling the molecular engine that drives malignant transformation. Hence, this notion may constitute a unifying principle that connects a large body of experimental results to clinical observations. Cancer Res; 71(21); 6572–5. ©2011 AACR.
- Published
- 2011
83. Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors
- Author
-
Teresa Guida, Alfredo Fusco, Marc Billaud, Francesca Carlomagno, Anderson J. Ryan, Massimo Santoro, Suresh Anaganti, Giancarlo Vecchio, Carlomagno, Francesca, Guida, T., Anaganti, S., Vecchio, Giancarlo, Fusco, Alfredo, Ryan, A. J., Billaud, M., and Santoro, Massimo
- Subjects
Cancer Research ,endocrine system diseases ,Drug Resistance ,Biology ,thyroid ,Cell Line ,tyrosine kinase inhibitor ,Piperidines ,Valine ,Cell surface receptor ,Catalytic Domain ,Proto-Oncogene Proteins ,Genetics ,Point Mutation ,Thyroid Neoplasms ,Enzyme Inhibitors ,Molecular Biology ,Kinase ,Proto-Oncogene Proteins c-ret ,Receptor Protein-Tyrosine Kinases ,Pyrimidines ,MEN2 ,Biochemistry ,Protein kinase domain ,Carcinoma, Medullary ,Quinazolines ,Pyrazoles ,Cyclin-dependent kinase 9 ,Mitogens ,Leucine ,Signal transduction ,RET ,Signal Transduction - Abstract
We have recently demonstrated that the pyrazolopyrimidines PP1 and PP2 and the 4-anilinoquinazoline ZD6474 display a strong inhibitory activity (IC(50)< or =100 nM) towards constitutively active oncogenic RET kinases. Here, we show that most oncogenic MEN2-associated RET kinase mutants are highly susceptible to PP1, PP2 and ZD6474 inhibition. In contrast, MEN2-associated swap of bulky hydrophobic leucine or methionine residues for valine 804 in the RET kinase domain causes resistance to the three compounds. Substitution of valine 804 with the small amino- acid glycine renders the RET kinase even more susceptible to inhibition (ZD6474 IC(50): 20 nM) than the wild-type kinase. Our data identify valine 804 of RET as a structural determinant mediating resistance to pyrazolopyrimidines and 4-anilinoquinazolines.
- Published
- 2004
- Full Text
- View/download PDF
84. Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase
- Author
-
Massimo Santoro, Satoshi Nagata, Marc Billaud, Ira Pastan, Giancarlo Vecchio, Giuliana Salvatore, Salvatore, Giuliana, Nagata, S., Billaud, M., Santoro, Massimo, Vecchio, Giancarlo, and Pastan, I.
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,endocrine system ,Glycosylation ,endocrine system diseases ,Immunoprecipitation ,medicine.drug_class ,Recombinant Fusion Proteins ,Biophysics ,Multiple endocrine neoplasia type 2 ,Enzyme-Linked Immunosorbent Assay ,Monoclonal antibody ,Biochemistry ,Receptor tyrosine kinase ,Mice ,Neoplasms ,Proto-Oncogene Proteins ,medicine ,Cytotoxic T cell ,Animals ,Drosophila Proteins ,Humans ,Molecular Biology ,neoplasms ,Mice, Inbred BALB C ,Hybridomas ,biology ,Proto-Oncogene Proteins c-ret ,Antibodies, Monoclonal ,Receptor Protein-Tyrosine Kinases ,tyrosine kinase ,Cell Biology ,medicine.disease ,Flow Cytometry ,Fusion protein ,Precipitin Tests ,Leukemia ,monoclonal antibody ,Cancer research ,biology.protein ,Antibody ,RET - Abstract
Ret is a tyrosine kinase receptor involved in several human diseases germ-line mutations are responsible for multiple endocrine neoplasia type 2 syndromes while somatic mutations of Ret are found in sporadic medullary thyroid carcinomas. In the present work, we describe the generation and characterization of a panel of novel monoclonal antibodies to Ret obtained by immunizing mice with a Ret-FC fusion protein. Fifty-five independent monoclonal antibodies recognize Ret-FC by enzyme linked immunosorbent assay but not a non-related FC fusion protein. Twenty antibodies further characterized recognize Ret expressing cells by flow cytometry. Finally, immunoprecipitation analysis showed that these antibodies recognize Ret mature glycosylated and immature forms. Thus, these monoclonal antibodies could be used as diagnostic tools to detect Ret expression, as well as therapeutic tools to downmodulate Ret or to deliver cytotoxic drugs to malignancies that overexpress Ret as neuroblastomas, medullary and papillary thyroid carcinomas, seminomas, and leukemia.
- Published
- 2002
85. The RET receptor: function in development and dysfunction in congenital malformation
- Author
-
Serge Manié, Marc Billaud, Alfredo Fusco, Massimo Santoro, Manie, S, Santoro, Massimo, Fusco, Alfredo, and Billaud, M.
- Subjects
endocrine system ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Glial Cell Line-Derived Neurotrophic Factor Receptors ,endocrine system diseases ,Multiple endocrine neoplasia type 2 ,Apoptosis ,Nerve Tissue Proteins ,Biology ,Ligands ,Proto-Oncogene Mas ,Receptor tyrosine kinase ,Enteric Nervous System ,Mice ,Germline mutation ,Membrane Microdomains ,Internal medicine ,Proto-Oncogene Proteins ,Genetics ,medicine ,Glial cell line-derived neurotrophic factor ,Animals ,Drosophila Proteins ,Humans ,Glial Cell Line-Derived Neurotrophic Factor ,Hirschsprung Disease ,Nerve Growth Factors ,Proto-Oncogene Proteins c-ret ,Neural crest ,Receptor Protein-Tyrosine Kinases ,medicine.disease ,Endocrinology ,Mutation ,Cancer research ,biology.protein ,Signal transduction ,Neural development ,Signal Transduction - Abstract
Germline mutations in the RET proto-oncogene are responsible for two unrelated neural crest disorders: Hirschsprung disease, a congenital absence of the enteric nervous system in the hindgut, and multiple endocrine neoplasia type 2, a dominantly inherited cancer syndrome. Moreover, somatic rearrangements of RET are causally involved in the genesis of papillary thyroid carcinoma. The receptor tyrosine kinase encoded by the RET gene acts as the subunit of a multimolecular complex that binds four distinct ligands and activates a signalling network crucial for neural and kidney development. Over the past few years, a clearer picture of the mode of RET activation and of its multifaceted role during development has started to emerge. These findings, which provide new clues to the molecular mechanisms underlying RET signalling dysfunction in Hirschsprung disease, are summarized in this review.
- Published
- 2001
86. Molecular mechanisms of Ret activation in human neoplasia
- Author
-
Marc Billaud, Alfredo Fusco, Giancarlo Vecchio, Francesca Carlomagno, Massimo Santoro, R. M. Melillo, Santoro, M., Carlomagno, F., Melillo, R. M., Billaud, M., Vecchio, Giancarlo, Fusco, A., Santoro, Massimo, Carlomagno, Francesca, Melillo, ROSA MARINA, M., Billaud, and Fusco, Alfredo
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,endocrine system ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,Receptor Protein-Tyrosine Kinases ,Multiple Endocrine Neoplasia Type 2a ,Multiple endocrine neoplasia type 2 ,Biology ,medicine.disease_cause ,Structure-Activity Relationship ,Endocrinology ,Germline mutation ,Proto-Oncogene Proteins ,medicine ,Animals ,Drosophila Proteins ,Humans ,Point Mutation ,genetics, Structure-Activity Relationship ,Germ-Line Mutation ,Genetics ,genetics, Receptor Protein-Tyrosine Kinase ,Kinase ,Point mutation ,Proto-Oncogene Proteins c-ret ,Autophosphorylation ,Animals, Drosophila Proteins, Germ-Line Mutation, Humans, Multiple Endocrine Neoplasia Type 2a ,medicine.disease ,genetics, Point Mutation, Proto-Oncogene Proteins c-ret, Proto-Oncogene Protein ,Cancer research ,Carcinogenesis - Abstract
Mutations that produce oncogenes with dominant gain of function may target receptor protein tyrosine kinases (PTK) in cancer and confer uncontrolled proliferation, impaired differentiation or unrestrained survival to the cancer cell. On the other hand, insufficient PTKs’ signaling may be responsible for developmental diseases. Gain of function of the RET receptor PTK is associated to human cancer. At the germ line level, point mutations of RET are responsible for multiple endocrine neoplasia type 2 (MEN2A, MEN2B and FMTC). Mutations of extracellular cysteines are found in MEN2A patients and a Met918Thr mutation is responsible for MEN2B. At the somatic level, gene rearrangements juxtaposing the TK domain of RET to heterologous gene partners are found in papillary carcinomas of the thyroid. These rearrangements generate the chimeric RET/PTC oncogenes. Both MEN2-associated point mutations and PTC-associated gene rearrangements potentiate the intrinsic TK activity of RET and, ultimately, the RET downstream signaling events. A multidocking site of the C-tail of RET is essential for both mitogenic and survival RET signalling. Such a site is involved in the recruitment of several intracellular molecules, like the She, FRS2 and IRS1 docking proteins and Enigma. The different activating mutations may also alter qualitatively the RET signaling properties either by altering RET autophosphorylation (in the case of the MEN2B mutation) or the subcellular distribution of the active kinase or providing the active kinase with a scaffold for novel protein-protein interactions (as in the case of RET/PTC oncoproteins). This review describes the molecular mechanisms by which the different genetic alterations cause the conversion of RET into a dominant transforming oncogene.
- Published
- 1999
87. Leveraging investments, promoting transparency and mobilising communities: a qualitative analysis of news articles about how the Ebola outbreak informed COVID-19 response in five African countries.
- Author
-
Courtney LP, Billaud M, Paulenich A, Chew R, Alidina Z, and Pinto M
- Subjects
- Humans, Africa epidemiology, Community Medicine, Datasets as Topic classification, Health Policy economics, Health Policy history, Health Policy trends, History, 21st Century, Leadership, Patient Compliance, Time Factors, Trust, COVID-19 economics, COVID-19 epidemiology, COVID-19 prevention & control, Disease Outbreaks economics, Disease Outbreaks prevention & control, Disease Outbreaks statistics & numerical data, Hemorrhagic Fever, Ebola economics, Hemorrhagic Fever, Ebola epidemiology, Hemorrhagic Fever, Ebola prevention & control, Investments statistics & numerical data, Mass Media statistics & numerical data, Public Health economics, Public Health education, Public Health methods, Public Health trends, Qualitative Research
- Abstract
Background: The WHO declared the novel COVID-19 outbreak a pandemic in March 2020. While the COVID-19 pandemic was unprecedented, prior experiences with diseases such as Middle East respiratory syndrome, severe acute respiratory syndrome and Ebola shaped many countries' preparedness and response strategies. Although lessons learnt from outbreak responses have been documented from a variety of sources, news media play a special role through their dissemination of news to the general public. This study investigated news media to explore how lessons learnt from the West African Ebola outbreak in 2014-2016 informed the COVID-19 responses in several African countries., Methods: We conducted qualitative analysis on a dataset of previously compiled COVID-19-related news articles published from 1 March 2020 to 31 August 2020. This dataset included 34,225 articles from 6 countries. We filtered the dataset to only include articles with the keyword 'Ebola'. We used a machine-learning text classification model to identify relevant articles with clear and specific lessons learnt. We conducted inductive and deductive coding to categorise lessons learnt and identify emergent themes., Results: Of the 861 articles containing the word 'Ebola', 18.4% (N=158) with lessons learnt from Ebola were included across five of the countries: Ethiopia, Ghana, Kenya, Liberia and Sierra Leone. News articles highlighted three emergent themes: the importance of leveraging existing resources and past response system investments, promoting transparency in public health messaging and engaging community leaders in all phases of the response., Conclusions: Findings suggest fostering trust prior to and throughout an outbreak facilitates timely implementation and compliance of mitigation strategies. Trust can be built by leveraging existing resources, being communicative and transparent about their funding allocation and decision-making and engaging communities., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
88. Only the strong "aorta" survives: the female edge in a mouse model of severe Marfan syndrome.
- Author
-
Billaud M and Phillippi JA
- Subjects
- Animals, Female, Mice, Aorta pathology, Aorta physiopathology, Aorta diagnostic imaging, Male, Sex Factors, Fibrillin-1 genetics, Fibrillin-1 metabolism, Marfan Syndrome complications, Marfan Syndrome genetics, Disease Models, Animal
- Published
- 2024
- Full Text
- View/download PDF
89. A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.
- Author
-
Al Assi A, Posty S, Lamarche F, Chebel A, Guitton J, Cottet-Rousselle C, Prudent R, Lafanechère L, Giraud S, Dallemagne P, Suzanne P, Verney A, Genestier L, Castets M, Fontaine E, Billaud M, and Cordier-Bussat M
- Subjects
- Animals, Humans, Mice, Cell Line, Tumor, Uncoupling Agents pharmacology, Oxidative Phosphorylation drug effects, Xenograft Model Antitumor Assays, Saccharomyces cerevisiae metabolism, Saccharomyces cerevisiae drug effects, Rats, NADH Dehydrogenase metabolism, NADH Dehydrogenase antagonists & inhibitors, Electron Transport Complex I metabolism, Electron Transport Complex I antagonists & inhibitors, Antineoplastic Agents pharmacology, Mitochondria metabolism, Mitochondria drug effects, Cell Proliferation drug effects, Saccharomyces cerevisiae Proteins
- Abstract
Cancer cells are highly dependent on bioenergetic processes to support their growth and survival. Disruption of metabolic pathways, particularly by targeting the mitochondrial electron transport chain complexes (ETC-I to V) has become an attractive therapeutic strategy. As a result, the search for clinically effective new respiratory chain inhibitors with minimized adverse effects is a major goal. Here, we characterize a new OXPHOS inhibitor compound called MS-L6, which behaves as an inhibitor of ETC-I, combining inhibition of NADH oxidation and uncoupling effect. MS-L6 is effective on both intact and sub-mitochondrial particles, indicating that its efficacy does not depend on its accumulation within the mitochondria. MS-L6 reduces ATP synthesis and induces a metabolic shift with increased glucose consumption and lactate production in cancer cell lines. MS-L6 either dose-dependently inhibits cell proliferation or induces cell death in a variety of cancer cell lines, including B-cell and T-cell lymphomas as well as pediatric sarcoma. Ectopic expression of Saccharomyces cerevisiae NADH dehydrogenase (NDI-1) partially restores the viability of B-lymphoma cells treated with MS-L6, demonstrating that the inhibition of NADH oxidation is functionally linked to its cytotoxic effect. Furthermore, MS-L6 administration induces robust inhibition of lymphoma tumor growth in two murine xenograft models without toxicity. Thus, our data present MS-L6 as an inhibitor of OXPHOS, with a dual mechanism of action on the respiratory chain and with potent antitumor properties in preclinical models, positioning it as the pioneering member of a promising drug class to be evaluated for cancer therapy. MS-L6 exerts dual mitochondrial effects: ETC-I inhibition and uncoupling of OXPHOS. In cancer cells, MS-L6 inhibited ETC-I at least 5 times more than in isolated rat hepatocytes. These mitochondrial effects lead to energy collapse in cancer cells, resulting in proliferation arrest and cell death. In contrast, hepatocytes which completely and rapidly inactivated this molecule, restored their energy status and survived exposure to MS-L6 without apparent toxicity., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
90. Androgenic steroids induce pathologic scarring in a preclinical porcine model via dysfunctional extracellular matrix deposition.
- Author
-
Reiche E, Keller PR, Soares V, Schuster CR, Rahmayanti S, Mroueh J, Mroueh V, Billaud M, Hu S, Hoover-Watson H, Lian CG, Tan Y, Doloff JC, Newell-Fugate AE, and Coon D
- Subjects
- Humans, Swine, Animals, Extracellular Matrix, Testosterone pharmacology, Collagen Type I, Laminin, Cicatrix, Hypertrophic
- Abstract
Hypertrophic scarring is a major source of morbidity. Sex hormones are not classically considered modulators of scarring. However, based on increased frequency of hypertrophic scarring in patients on testosterone, we hypothesized that androgenic steroids induce abnormal scarring and developed a preclinical porcine model to explore these effects. Mini-swine underwent castration, received no testosterone (noT) or biweekly testosterone therapy (+T), and underwent excisional wounding. To create a delayed wound healing model, a subset of wounds were re-excised at 2 weeks. Scars from postoperative day 42 (POD42) and delayed wounds (POD28) were harvested 6 weeks after initial wounding for analysis via histology, bulk RNA-seq, and mechanical testing. Histologic analysis of scars from +T animals showed increased mean fibrosis area (16 mm
2 noT, 28 mm2 +T; p = .007) and thickness (0.246 mm2 noT, 0.406 mm2 +T; p < .001) compared to noT. XX+T and XY+T scars had greater tensile burst strength (p = .024 and p = .013, respectively) compared to noT swine. Color deconvolution analysis revealed greater deposition of type I and type III collagen as well as increased collagen type I:III ratio in +T scars. Dermatopathologist histology scoring showed that +T exposure was associated with worse overall scarring (p < .05). Gene ontology analysis found that testosterone exposure was associated with upregulation of cellular metabolism and immune response gene sets, while testosterone upregulated pathways related to keratinization and laminin formation on pathway analysis. In conclusion, we developed a preclinical porcine model to study the effects of the sex hormone testosterone on scarring. Testosterone induces increased scar tissue deposition and appears to increase physical strength of scars via supraphysiologic deposition of collagen and other ECM factors. The increased burst strength seen in both XX and XY animals suggests that hormone administration has a strong influence on scar mechanical properties independent of chromosomal sex. Anti-androgen topical therapies may be a promising future area of research., (© 2024 Federation of American Societies for Experimental Biology.)- Published
- 2024
- Full Text
- View/download PDF
91. Impact of rising seawater temperature on a phagocytic cell population during V. parahaemolyticus infection in the sea anemone E. pallida .
- Author
-
Billaud M, Larbret F, and Czerucka D
- Subjects
- Animals, Humans, Temperature, Seawater, Phagocytes, Sea Anemones metabolism, Sea Anemones microbiology, Vibrio parahaemolyticus physiology
- Abstract
Climate change is increasing ocean temperatures and consequently impacts marine life (e.g., bacterial communities). In this context, studying host-pathogen interactions in marine organisms is becoming increasingly important, not only for ecological conservation, but also to reduce economic loss due to mass mortalities in cultured species. In this study, we used Exaiptasia pallida ( E. pallida ), an anemone, as an emerging marine model to better understand the effect of rising temperatures on the infection induced by the pathogenic marine bacterium Vibrio parahaemolyticus . The effect of temperature on E. pallida was examined at 6, 24, or 30 h after bath inoculation with 10
8 CFU of V. parahaemolyticus expressing GFP (Vp-GFP) at 27°C (husbandry temperature) or 31°C (heat stress). Morphological observations of E. pallida and their Hsps expression demonstrated heat stress induced increasing damage to anemones. The kinetics of the infections revealed that Vp-GFP were localized on the surface of the ectoderm and in the mucus during the first hours of infection and in the mesenterial filaments thereafter. To better identify the E. pallida cells targeted by Vp-GFP infection, we used spectral flow cytometry. E. pallida cell types were identified based on their autofluorescent properties. corresponding to different cell types (algae and cnidocytes). We identified an AF10 population whose autofluorescent spectrum was identical to that of human monocytes/macrophage, suggesting that this spectral print could be the hallmark of phagocytic cells called "amebocytes''. AF10 autofluorescent cells had a high capacity to phagocytize Vp-GFP, suggesting their possible role in fighting infection. This was confirmed by microscopy using sorted AF10 and GFP-positive cells (AF10+/GFP+). The number of AF10+/GFP+ cells were reduced at 31°C, demonstrating that increased temperature not only damages tissue but also affects the immune response of E. pallida . In conclusion, our study provides a springboard for more comprehensive studies of immune defense in marine organisms and paves the way for future studies of the dynamics, activation patterns, and functional responses of immune cells when encountering pathogens., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Billaud, Larbret and Czerucka.)- Published
- 2023
- Full Text
- View/download PDF
92. Functions of LKB1 in neural crest development: The story unfolds.
- Author
-
Thibert C, Lucas A, Billaud M, Torch S, Mével-Aliset M, and Allard J
- Subjects
- Signal Transduction, Neural Tube, Schwann Cells, Cell Movement physiology, Cell Differentiation, Neural Crest metabolism, Neural Stem Cells
- Abstract
Neural crest cells (NCCs) are highly motile, multipotent, embryonic cells that delaminate from the dorsal edges of the neural tube. NCCs follow stereotypical long-range migratory pathways to reach target organs during development, where they give rise to multiple derivatives. The identification of reservoirs of neural crest stem cells that persist to adulthood has recently aroused renewed interest in the biology of NCCs. In this context, several recent studies have demonstrated the essential role of the metabolic kinase LKB1 in NCC establishment. This review surveys how LKB1 governs the formation and maintenance of several neural crest derivatives, including facial bones, melanocytes, Schwann cells, and the enteric nervous system. We also detail the underlying molecular mechanisms that involve downstream effectors of LKB1, in particular the contribution of the AMPK-mTOR signaling pathway to both polarity and metabolic processes. Collectively, these recent discoveries open promising perspectives for new therapeutic applications for the treatment of neural crest disorders., (© 2023 The Authors. Developmental Dynamics published by Wiley Periodicals LLC on behalf of American Association for Anatomy.)
- Published
- 2023
- Full Text
- View/download PDF
93. The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.
- Author
-
Bisaccia J, Meyer S, Bertrand-Chapel A, Hecquet Q, Barbet V, Kaniewski B, Léon S, Gadot N, Rochet I, Fajnorova I, Leblond P, Cordier-Bussat M, Corradini N, Vasiljevic A, Billaud M, Picard C, Broutier L, Gallerne C, Dutour A, Blay JY, and Castets M
- Abstract
Toll-like receptor 3 (TLR3) is a pattern recognition receptor mainly known for its role in innate immune response to infection. Indeed, binding of double-stranded RNA (dsRNA) to TLR3 triggers a pro-inflammatory cascade leading to cytokine release and immune cell activation. Its anti-tumoral potential has emerged progressively, associated with a direct impact on tumor cell death induction and with an indirect action on immune system reactivation. Accordingly, TLR3 agonists are currently being tested in clinical trials for several adult cancers. Meanwhile, TLR3 variants have been linked to auto-immune disorders, and as risk factors of viral infection and cancers. However, aside from neuroblastoma, TLR3 role in childhood cancers has not been evaluated. Here, by integrating public transcriptomic data of pediatric tumors, we unveil that high TLR3 expression is largely associated with a better prognosis in childhood sarcomas. Using osteosarcomas and rhabdomyosarcomas as models, we show that TLR3 efficiently drives tumor cell death in vitro and induces tumor regression in vivo. Interestingly, this anti-tumoral effect was lost in cells expressing the homozygous TLR3 L412F polymorphism, which is enriched in a rhabdomyosarcomas cohort. Thus, our results demonstrate the therapeutic potential associated with the targeting of TLR3 in pediatric sarcomas, but also the need to stratify patients eligible for this clinical approach with respect to the TLR3 variants expressed., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
94. [Preventable cancers: Is it enough to change our behaviour?]
- Author
-
Billaud M, Castets M, Trautmann A, and Sujobert P
- Subjects
- Humans, Life Style, France, Risk Factors, Neoplasms etiology, Occupational Exposure
- Abstract
In France, part of 40 % of preventable cancers can be attributed to lifestyle habits. Epidemiological data show that occupational exposures are a major cause of these cancers. However, despite this evidence, the prevention actions promoted by public authorities are focused on changing individual behaviors. In this article, we seek to understand the reasons of the erasure of the role of socio-environmental factors in cancer prevention discourse., (© 2023 médecine/sciences – Inserm.)
- Published
- 2023
- Full Text
- View/download PDF
95. Editorial: Women in heart valve disease.
- Author
-
Veulemans V, Billaud M, Nunes MCP, Goettsch C, and Aikawa E
- Abstract
Competing Interests: Author VV has received consulting fees, travel expenses, or study honoraria from Medtronic, Edwards Lifesciences, and Boston Scientific. Author EA serves on scientific board for Elastrin Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
96. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.
- Author
-
Delage L, Lambert M, Bardel É, Kundlacz C, Chartoire D, Conchon A, Peugnet AL, Gorka L, Auberger P, Jacquel A, Soussain C, Destaing O, Delecluse HJ, Delecluse S, Merabet S, Traverse-Glehen A, Salles G, Bachy E, Billaud M, Ghesquières H, Genestier L, Rouault JP, and Sujobert P
- Subjects
- Humans, Mutation, Genes, cdc, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Crk-Associated Substrate Protein genetics, Crk-Associated Substrate Protein metabolism, Lymphoma, Large B-Cell, Diffuse pathology
- Abstract
Understanding the functional role of mutated genes in cancer is required to translate the findings of cancer genomics into therapeutic improvement. BTG1 is recurrently mutated in the MCD/C5 subtype of diffuse large B-cell lymphoma (DLBCL), which is associated with extranodal dissemination. Here, we provide evidence that Btg1 knock out accelerates the development of a lethal lymphoproliferative disease driven by Bcl2 overexpression. Furthermore, we show that the scaffolding protein BCAR1 is a BTG1 partner. Moreover, after BTG1 deletion or expression of BTG1 mutations observed in patients with DLBCL, the overactivation of the BCAR1-RAC1 pathway confers increased migration ability in vitro and in vivo. These modifications are targetable with the SRC inhibitor dasatinib, which opens novel therapeutic opportunities in BTG1 mutated DLBCL., (© 2023 by The American Society of Hematology.)
- Published
- 2023
- Full Text
- View/download PDF
97. Amount of Pannexin 1 in Smooth Muscle Cells Regulates Sympathetic Nerve-Induced Vasoconstriction.
- Author
-
Dunaway LS, Billaud M, Macal E, Good ME, Medina CB, Lorenz U, Ravichandran K, Koval M, and Isakson BE
- Subjects
- Humans, Mice, Animals, Sympathetic Nervous System physiology, Blood Pressure physiology, Myocytes, Smooth Muscle metabolism, Connexins genetics, Connexins metabolism, Adenosine Triphosphate metabolism, Adenosine Triphosphate pharmacology, Nerve Tissue Proteins genetics, Nerve Tissue Proteins metabolism, Vasoconstriction, Spironolactone pharmacology
- Abstract
Background: Panx1 (pannexin 1) forms high conductance channels that secrete ATP upon stimulation. The role of Panx1 in mediating constriction in response to direct sympathetic nerve stimulation is not known. Additionally, it is unknown how the expression level of Panx1 in smooth muscle cells (SMCs) influences α-adrenergic responses. We hypothesized that the amount of Panx1 in SMCs dictates the levels of sympathetic constriction and blood pressure., Methods: To test this hypothesis, we used genetically modified mouse models enabling expression of Panx1 in vascular cells to be varied. Electrical field stimulation on isolated arteries and blood pressure were assessed., Results: Genetic deletion of SMC Panx1 prevented constriction by electric field stimulation of sympathetic nerves. Conversely, overexpression of Panx1 in SMCs using a ROSA26 transgenic model increased sympathetic nerve-mediated constriction. Connexin 43 hemichannel inhibitors did not alter constriction. Next, we evaluated the effects of altered SMC Panx1 expression on blood pressure. To do this, we created mice combining a global Panx1 deletion, with ROSA26-Panx1 under the control of an inducible SMC specific Cre (Myh11). This resulted in mice that could express only human Panx1, only in SMCs. After tamoxifen, these mice had increased blood pressure that was acutely decreased by the Panx1 inhibitor spironolactone. Control mice genetically devoid of Panx1 did not respond to spironolactone., Conclusions: These data suggest Panx1 in SMCs could regulate the extent of sympathetic nerve constriction and blood pressure. The results also show the feasibility humanized Panx1-mouse models to test pharmacological candidates.
- Published
- 2023
- Full Text
- View/download PDF
98. The Clostridium-infecting filamentous phage CAK1 genome analysis allows to define a new potential clade of Tubulavirales.
- Author
-
Billaud M, Petit MA, and Lossouarn J
- Subjects
- Animals, Swine, Genome, Clostridium genetics, Computational Biology, Genome, Viral, Phylogeny, Viruses genetics, Bacteriophages genetics
- Abstract
What we know about Tubulavirales, i.e. filamentous phages, essentially comes from Gram-negative-infecting Inoviridae. However, metagenomics recently suggests filamentous phages are much more widespread and diverse. Here, we report the complete sequence and functional annotation of CAK1, a 6.6 kb filamentous phage that was shown to chronically infect Clostridium beijerinckii 30 years ago and only represents the second filamentous phage cultivated on a Gram-positive bacterium. CAK1 has a typical filamentous phage modular genome with no homologs in databases and we were interested to compare it with a pig gut filamentous phage metagenomics dataset that we previously assembled and for which many filamentous phages were predicted to infect Clostridium species by bioinformatics means. CAK1 is distantly related to nine of these sequences, two of which have been predicted as Clostridium-associated. In itself, this small cluster of CAK1-connected sequences sheds light on the diversity of filamentous phages that putatively infect Clostridium species, and probably many other Gram-positive genera., (© The Author(s) 2023. Published by Oxford University Press on behalf of FEMS.)
- Published
- 2023
- Full Text
- View/download PDF
99. Adventitia-derived extracellular matrix hydrogel enhances contractility of human vasa vasorum-derived pericytes via α 2 β 1 integrin and TGFβ receptor.
- Author
-
Wintruba KL, Hill JC, Richards TD, Lee YC, Kaczorowski DJ, Sultan I, Badylak SF, Billaud M, Gleason TG, and Phillippi JA
- Subjects
- Animals, Biocompatible Materials metabolism, Collagen Type I metabolism, Extracellular Matrix, Humans, Hydrogels metabolism, Hydrogels pharmacology, Integrins metabolism, Pericytes, Swine, Transforming Growth Factor beta metabolism, Adventitia metabolism, Vasa Vasorum metabolism
- Abstract
Pericytes are essential components of small blood vessels and are found in human aortic vasa vasorum. Prior work uncovered lower vasa vasorum density and decreased levels of pro-angiogenic growth factors in adventitial specimens of human ascending thoracic aortic aneurysm. We hypothesized that adventitial extracellular matrix (ECM) from normal aorta promotes pericyte function by increasing pericyte contractile function through mechanisms deficient in ECM derived from aneurysmal aortic adventitia. ECM biomaterials were prepared as lyophilized particulates from decellularized adventitial specimens of human and porcine aorta. Immortalized human aortic adventitia-derived pericytes were cultured within Type I collagen gels in the presence or absence of human or porcine adventitial ECMs. Cell contractility index was quantified by measuring the gel area immediately following gelation and after 48 h of culture. Normal human and porcine adventitial ECM increased contractility of pericytes when compared with pericytes cultured in absence of adventitial ECM. In contrast, aneurysm-derived human adventitial ECM failed to promote pericyte contractility. Pharmacological inhibition of TGFβR1 and antibody blockade of α
2 β1 integrin independently decreased porcine adventitial ECM-induced pericyte contractility. By increasing pericyte contractility, adventitial ECM may improve microvascular function and thus represents a candidate biomaterial for less invasive and preventative treatment of human ascending aortic disease., (© 2022 Wiley Periodicals LLC.)- Published
- 2022
- Full Text
- View/download PDF
100. Aortic Dissection is Determined by Specific Shape and Hemodynamic Interactions.
- Author
-
Williams JG, Marlevi D, Bruse JL, Nezami FR, Moradi H, Fortunato RN, Maiti S, Billaud M, Edelman ER, and Gleason TG
- Subjects
- Humans, Aorta, Aorta, Thoracic diagnostic imaging, Hemodynamics, Aortic Dissection diagnostic imaging
- Abstract
The aim of this study was to determine whether specific three-dimensional aortic shape features, extracted via statistical shape analysis (SSA), correlate with the development of thoracic ascending aortic dissection (TAAD) risk and associated aortic hemodynamics. Thirty-one patients followed prospectively with ascending thoracic aortic aneurysm (ATAA), who either did (12 patients) or did not (19 patients) develop TAAD, were included in the study, with aortic arch geometries extracted from computed tomographic angiography (CTA) imaging. Arch geometries were analyzed with SSA, and unsupervised and supervised (linked to dissection outcome) shape features were extracted with principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA), respectively. We determined PLS-DA to be effective at separating dissection and no-dissection patients ([Formula: see text]), with decreased tortuosity and more equal ascending and descending aortic diameters associated with higher dissection risk. In contrast, neither PCA nor traditional morphometric parameters (maximum diameter, tortuosity, or arch volume) were effective at separating dissection and no-dissection patients. The arch shapes associated with higher dissection probability were supported with hemodynamic insight. Computational fluid dynamics (CFD) simulations revealed a correlation between the PLS-DA shape features and wall shear stress (WSS), with higher maximum WSS in the ascending aorta associated with increased risk of dissection occurrence. Our work highlights the potential importance of incorporating higher dimensional geometric assessment of aortic arch anatomy in TAAD risk assessment, and in considering the interdependent influences of arch shape and hemodynamics as mechanistic contributors to TAAD occurrence., (© 2022. The Author(s) under exclusive licence to Biomedical Engineering Society.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.